Literature DB >> 26228886

Comparison of the Diagnostic Accuracy of DSC- and Dynamic Contrast-Enhanced MRI in the Preoperative Grading of Astrocytomas.

T B Nguyen1, G O Cron2, K Perdrizet3, K Bezzina4, C H Torres2, S Chakraborty2, J Woulfe5, G H Jansen5, J Sinclair6, R E Thornhill2, C Foottit7, B Zanette8, I G Cameron9.   

Abstract

BACKGROUND AND
PURPOSE: Dynamic contrast-enhanced MR imaging parameters can be biased by poor measurement of the vascular input function. We have compared the diagnostic accuracy of dynamic contrast-enhanced MR imaging by using a phase-derived vascular input function and "bookend" T1 measurements with DSC MR imaging for preoperative grading of astrocytomas.
MATERIALS AND METHODS: This prospective study included 48 patients with a new pathologic diagnosis of an astrocytoma. Preoperative MR imaging was performed at 3T, which included 2 injections of 5-mL gadobutrol for dynamic contrast-enhanced and DSC MR imaging. During dynamic contrast-enhanced MR imaging, both magnitude and phase images were acquired to estimate plasma volume obtained from phase-derived vascular input function (Vp_Φ) and volume transfer constant obtained from phase-derived vascular input function (K(trans)_Φ) as well as plasma volume obtained from magnitude-derived vascular input function (Vp_SI) and volume transfer constant obtained from magnitude-derived vascular input function (K(trans)_SI). From DSC MR imaging, corrected relative CBV was computed. Four ROIs were placed over the solid part of the tumor, and the highest value among the ROIs was recorded. A Mann-Whitney U test was used to test for difference between grades. Diagnostic accuracy was assessed by using receiver operating characteristic analysis.
RESULTS: Vp_ Φ and K(trans)_Φ values were lower for grade II compared with grade III astrocytomas (P < .05). Vp_SI and K(trans)_SI were not significantly different between grade II and grade III astrocytomas (P = .08-0.15). Relative CBV and dynamic contrast-enhanced MR imaging parameters except for K(trans)_SI were lower for grade III compared with grade IV (P ≤ .05). In differentiating low- and high-grade astrocytomas, we found no statistically significant difference in diagnostic accuracy between relative CBV and dynamic contrast-enhanced MR imaging parameters.
CONCLUSIONS: In the preoperative grading of astrocytomas, the diagnostic accuracy of dynamic contrast-enhanced MR imaging parameters is similar to that of relative CBV.
© 2015 by American Journal of Neuroradiology.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26228886      PMCID: PMC7964869          DOI: 10.3174/ajnr.A4398

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  23 in total

1.  Phase-based arterial input function measurements for dynamic susceptibility contrast MRI.

Authors:  Egbert J W Bleeker; Mark A van Buchem; Andrew G Webb; Matthias J P van Osch
Journal:  Magn Reson Med       Date:  2010-08       Impact factor: 4.668

2.  In vivo quantification of contrast agent concentration using the induced magnetic field for time-resolved arterial input function measurement with MRI.

Authors:  Ludovic de Rochefort; Thanh Nguyen; Ryan Brown; Pascal Spincemaille; Grace Choi; Jonathan Weinsaft; Martin R Prince; Yi Wang
Journal:  Med Phys       Date:  2008-12       Impact factor: 4.071

3.  Perfusion magnetic resonance imaging: comparison of semiologic characteristics in first-pass perfusion of brain tumors at 1.5 and 3 Tesla.

Authors:  Natacha Mauz; Alexandre Krainik; Irène Tropres; Laurent Lamalle; Elodie Sellier; Omer Eker; Florence Tahon; Jean-François Le Bas; Sylvie Grand
Journal:  J Neuroradiol       Date:  2012-02-16       Impact factor: 3.447

4.  Is volume transfer coefficient (K(trans)) related to histologic grade in human gliomas?

Authors:  Tufail F Patankar; Hamied A Haroon; Samantha J Mills; Danielle Balériaux; David L Buckley; Geoff J M Parker; Alan Jackson
Journal:  AJNR Am J Neuroradiol       Date:  2005 Nov-Dec       Impact factor: 3.825

5.  Relative cerebral blood volume maps corrected for contrast agent extravasation significantly correlate with glioma tumor grade, whereas uncorrected maps do not.

Authors:  J L Boxerman; K M Schmainda; R M Weisskoff
Journal:  AJNR Am J Neuroradiol       Date:  2006-04       Impact factor: 3.825

6.  Brain tumor perfusion: comparison of dynamic contrast enhanced magnetic resonance imaging using T1, T2, and T2* contrast, pulsed arterial spin labeling, and H2(15)O positron emission tomography.

Authors:  Lutz Lüdemann; Carsten Warmuth; Michail Plotkin; Annette Förschler; Matthias Gutberlet; Peter Wust; Holger Amthauer
Journal:  Eur J Radiol       Date:  2008-03-24       Impact factor: 3.528

7.  Role of perfusion CT in glioma grading and comparison with conventional MR imaging features.

Authors:  S K Ellika; R Jain; S C Patel; L Scarpace; L R Schultz; J P Rock; T Mikkelsen
Journal:  AJNR Am J Neuroradiol       Date:  2007-09-24       Impact factor: 3.825

8.  Glioma grading by using histogram analysis of blood volume heterogeneity from MR-derived cerebral blood volume maps.

Authors:  Kyrre E Emblem; Baard Nedregaard; Terje Nome; Paulina Due-Tonnessen; John K Hald; David Scheie; Olivera Casar Borota; Milada Cvancarova; Atle Bjornerud
Journal:  Radiology       Date:  2008-06       Impact factor: 11.105

9.  Improvement in breast lesion characterization with dynamic contrast-enhanced MRI using pharmacokinetic modeling and bookend T(1) measurements.

Authors:  Greg O Cron; Frederick Kelcz; Giles E Santyr
Journal:  Magn Reson Med       Date:  2004-05       Impact factor: 4.668

10.  Assessment of the pathological grade of astrocytic gliomas using an MRI score.

Authors:  S Asari; T Makabe; S Katayama; T Itoh; S Tsuchida; T Ohmoto
Journal:  Neuroradiology       Date:  1994-05       Impact factor: 2.804

View more
  16 in total

1.  Prognosis prediction of non-enhancing T2 high signal intensity lesions in glioblastoma patients after standard treatment: application of dynamic contrast-enhanced MR imaging.

Authors:  Rihyeon Kim; Seung Hong Choi; Tae Jin Yun; Soon-Tae Lee; Chul-Kee Park; Tae Min Kim; Ji-Hoon Kim; Sun-Won Park; Chul-Ho Sohn; Sung-Hye Park; Il Han Kim
Journal:  Eur Radiol       Date:  2016-06-29       Impact factor: 5.315

2.  Reproducibility of dynamic contrast-enhanced MRI and dynamic susceptibility contrast MRI in the study of brain gliomas: a comparison of data obtained using different commercial software.

Authors:  Gian Marco Conte; Antonella Castellano; Luisa Altabella; Antonella Iadanza; Marcello Cadioli; Andrea Falini; Nicoletta Anzalone
Journal:  Radiol Med       Date:  2017-01-09       Impact factor: 3.469

3.  Comparison of T1 mapping and fixed T1 method for dynamic contrast-enhanced MRI perfusion in brain gliomas.

Authors:  G M Conte; L Altabella; A Castellano; V Cuccarini; A Bizzi; M Grimaldi; A Costa; M Caulo; A Falini; N Anzalone
Journal:  Eur Radiol       Date:  2019-04-10       Impact factor: 5.315

Review 4.  Discrimination between Glioma Grades II and III Using Dynamic Susceptibility Perfusion MRI: A Meta-Analysis.

Authors:  Anna F Delgado; Alberto F Delgado
Journal:  AJNR Am J Neuroradiol       Date:  2017-05-18       Impact factor: 3.825

5.  Volumetric Measurement of Relative CBV Using T1-Perfusion-Weighted MRI with High Temporal Resolution Compared with Traditional T2*-Perfusion-Weighted MRI in Postoperative Patients with High-Grade Gliomas.

Authors:  M Seo; K-J Ahn; Y Choi; N-Y Shin; J Jang; B-S Kim
Journal:  AJNR Am J Neuroradiol       Date:  2022-05-26       Impact factor: 4.966

6.  3D Pseudocontinuous Arterial Spin-Labeling MR Imaging in the Preoperative Evaluation of Gliomas.

Authors:  Q Zeng; B Jiang; F Shi; C Ling; F Dong; J Zhang
Journal:  AJNR Am J Neuroradiol       Date:  2017-07-20       Impact factor: 3.825

7.  Pediatric astrocytic tumor grading: comparison between arterial spin labeling and dynamic susceptibility contrast MRI perfusion.

Authors:  Giovanni Morana; Domenico Tortora; Serena Staglianò; Paolo Nozza; Samantha Mascelli; Mariasavina Severino; Gianluca Piatelli; Alessandro Consales; Maarten Lequin; Maria Luisa Garrè; Andrea Rossi
Journal:  Neuroradiology       Date:  2018-02-16       Impact factor: 2.804

Review 8.  Clinical Applications of Contrast-Enhanced Perfusion MRI Techniques in Gliomas: Recent Advances and Current Challenges.

Authors:  Junfeng Zhang; Heng Liu; Haipeng Tong; Sumei Wang; Yizeng Yang; Gang Liu; Weiguo Zhang
Journal:  Contrast Media Mol Imaging       Date:  2017-03-20       Impact factor: 3.161

9.  Specific Preoperative Dynamic Contrast-Enhanced MRI Semi-quantitative Markers Can Correlate With Vascularity in Specific Areas of Glioblastoma Tissue and Predict Recurrence.

Authors:  Mohammed A Azab; Sherief Ghozy; Sherif F Hassanein; Ahmed Y Azzam
Journal:  Cureus       Date:  2021-06-08

Review 10.  MRI in Glioma Immunotherapy: Evidence, Pitfalls, and Perspectives.

Authors:  Domenico Aquino; Andrea Gioppo; Gaetano Finocchiaro; Maria Grazia Bruzzone; Valeria Cuccarini
Journal:  J Immunol Res       Date:  2017-04-20       Impact factor: 4.818

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.